PTGX
Protagonist Therapeutics, Inc.
$127.16+2.49 (+2.00%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Aug 11, 2016 – Nov 18, 2026, Dividends reinvested
- Final balance
- $108,684
- CAGR
- +26.15%
- Max drawdown
- −85.79%
Trailing returns (%)
PTGX's average annual return was 17.60% over the last 10 years, through Nov 18, 2026. $10,000 in PTGX on Nov 18, 2016 grew to $50,601 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- −1.23%
- 3M
- −19.18%
- 6M
- +26.23%
- YTD
- +45.59%
- 1Y
- +50.68%
Per year
- 3Y
- +96.30%
- 5Y
- +28.42%
- 10Y
- +17.60%
- Since 2016
- +26.15%
Annual returns
2016 from Aug 11 · 2026 through Nov 18
PTGX returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | +45.59% |
| 2025 | +126.27% |
| 2024 | +68.34% |
| 2023 | +110.17% |
| 2022 | −68.10% |
| 2021 | +69.64% |
| 2020 | +185.96% |
| 2019 | +4.75% |
| 2018 | −67.64% |
| 2017 | −5.41% |
| 2016 from Aug 11 | +87.95% |
Metrics
Since 2016| Volatility | 89.20% |
|---|---|
| Sharpe ratio | 0.70 |
| Sortino ratio | 1.16 |
| Calmar ratio | 0.30 |
| Longest drawdown | 4.2 years |
Worst drawdowns
Since 2016| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −85.8% | Sep 2021 | Jun 2022 | Mar 2025 | 3.5 years |
| −82.1% | Dec 2016 | Dec 2019 | Feb 2021 | 4.2 years |
| −31.6% | Mar 2025 | Apr 2025 | Aug 2025 | 6 months |
| −21.4% | Aug 2026 | Nov 2026 | Not yet | 3 months so far |
| −20.3% | Oct 2016 | Nov 2016 | Nov 2016 | 3 weeks |